FIELD: medicine.
SUBSTANCE: invention refers to medicine, ophthalmology. A method involves a sinus trabeculectomy, a local sclerectomy and a drug delivery to a posterior pole of eyeball following by a restorative treatment. The local sclerectomy is performed in an inferior-internal segment of the eye with a cross-section of the incision being semi-circular. The local sclerectomy uses Histochrom as a drug substance. The restorative treatment comprises subconjunctival drug injections in a combination with the exposure to a physical factor. Starting from the first postoperative day, Histochrom is injected into a sub-Tenon's space. There are 9 injections performed once a day. Starting from the second postoperative day, a magnetic stimulation is used at frequency 100 Hz, length 16 minutes once a day for 7-10 days. The first 3 sessions involve the exposure to a pulsating monopolar magnetic field of intensity 6.25 mT. The following 4-7 sessions involve the exposure to an alternating bipolar magnetic field of intensity 12.5 mT.
EFFECT: method provides stabilising and enhancing the visual functions.
5 cl, 1 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING GLAUCOMATOUS NEUROPATHY | 2006 |
|
RU2308916C1 |
METHOD FOR TREATING PRIMARY UNSTABILIZED OPEN-ANGLE GLAUCOMA AT PSEUDONORMAL PRESSURE | 2004 |
|
RU2254840C1 |
METHOD FOR COMBINED TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY | 2015 |
|
RU2576785C1 |
METHOD OF TREATING VISUAL NERVE AND RETINAL DISEASES | 2010 |
|
RU2447864C1 |
IMPLANT FOR POSTERIOR POLE REVASCULARISATION IN PATIENTS WITH GLAUCOMA | 2014 |
|
RU2557915C1 |
METHOD FOR NON-PENETRATING DEEP SCLERECTOMY WITH LENTICULAR TISSUE DRAINAGE FOR PRIMARY OPEN-ANGLE GLAUCOMA | 2023 |
|
RU2809524C1 |
SURGICAL METHOD FOR TREATING GLAUCOMA CASES | 2006 |
|
RU2315585C1 |
METHOD FOR IMPROVING AQUEOUS HUMOR DISCHARGE FROM EYE IN OPEN ANGLE GLAUCOMA CASES | 2006 |
|
RU2315587C1 |
METHOD OF TREATING INVOLUTIONAL EYE DISEASES | 2011 |
|
RU2565840C2 |
METHOD FOR INTRODUCING DRUGS WHEN TREATING PATIENTS FOR POSTERIOR EYE SEGMENT DISEASES | 2004 |
|
RU2278640C1 |
Authors
Dates
2014-03-27—Published
2013-01-21—Filed